-
Je něco špatně v tomto záznamu ?
Visceral obesity and HFpEF: targets and therapeutic opportunities
Y. Li, Z. Lin, Y. Li
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
- MeSH
- abdominální obezita * farmakoterapie komplikace patofyziologie metabolismus MeSH
- lidé MeSH
- nitrobřišní tuk metabolismus MeSH
- srdeční selhání * farmakoterapie patofyziologie MeSH
- tepový objem MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The effectiveness of weight-loss drugs in heart failure (HF) with preserved ejection fraction (HFpEF) highlights the link between obesity (adipose tissue) and HF (the heart). Recent guidelines incorporating the waist:height ratio for diagnosing and treating obesity reflect the growing recognition of the significance of visceral adiposity. However, its unique impact on HFpEF and their complex relationship remain underexplored. With limited treatment options for obesity-related HFpEF, novel disease-modifying treatments are urgently needed. Here, we clarify the relationship between visceral obesity and HFpEF, introducing the concept of the visceral adipose tissue-heart axis to explore its mechanisms and therapeutic potential. We also discuss promising strategies targeting visceral obesity in HFpEF and propose directions for future research.
School of Pharmaceutical Sciences Wenzhou Medical University Wenzhou 325035 China
The Innovation Center of Cardiometabolic Disease Guangdong Medical University Dongguan 523808 China
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25016241
- 003
- CZ-PrNML
- 005
- 20250731091630.0
- 007
- ta
- 008
- 250708s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.tips.2025.02.005 $2 doi
- 035 __
- $a (PubMed)40113531
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Li, Yilin $u Beijing Anzhen Hospital, Capital Medical University, Key Laboratory of the Ministry of Education for Cardiovascular Remodeling-Related Diseases, Beijing Collaborative Innovative Research Center for Cardiovascular Diseases, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China
- 245 10
- $a Visceral obesity and HFpEF: targets and therapeutic opportunities / $c Y. Li, Z. Lin, Y. Li
- 520 9_
- $a The effectiveness of weight-loss drugs in heart failure (HF) with preserved ejection fraction (HFpEF) highlights the link between obesity (adipose tissue) and HF (the heart). Recent guidelines incorporating the waist:height ratio for diagnosing and treating obesity reflect the growing recognition of the significance of visceral adiposity. However, its unique impact on HFpEF and their complex relationship remain underexplored. With limited treatment options for obesity-related HFpEF, novel disease-modifying treatments are urgently needed. Here, we clarify the relationship between visceral obesity and HFpEF, introducing the concept of the visceral adipose tissue-heart axis to explore its mechanisms and therapeutic potential. We also discuss promising strategies targeting visceral obesity in HFpEF and propose directions for future research.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a srdeční selhání $x farmakoterapie $x patofyziologie $7 D006333
- 650 12
- $a abdominální obezita $x farmakoterapie $x komplikace $x patofyziologie $x metabolismus $7 D056128
- 650 _2
- $a tepový objem $7 D013318
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nitrobřišní tuk $x metabolismus $7 D050152
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Lin, Zhuofeng $u The Innovation Center of Cardiometabolic Disease, Guangdong Medical University, Dongguan 523808, China; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China. Electronic address: zlin@gdmu.edu.cn
- 700 1_
- $a Li, Yulin $u Beijing Anzhen Hospital, Capital Medical University, Key Laboratory of the Ministry of Education for Cardiovascular Remodeling-Related Diseases, Beijing Collaborative Innovative Research Center for Cardiovascular Diseases, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China. Electronic address: lyllyl_1111@163.com
- 773 0_
- $w MED00010701 $t Trends in pharmacological sciences $x 1873-3735 $g Roč. 46, č. 4 (2025), s. 337-356
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40113531 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091624 $b ABA008
- 999 __
- $a ok $b bmc $g 2366822 $s 1253366
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 46 $c 4 $d 337-356 $e 20250319 $i 1873-3735 $m Trends in pharmacological sciences $n Trends Pharmacol Sci $x MED00010701
- LZP __
- $a Pubmed-20250708
